glp 1 multiple endocrine neoplasia GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Beyond glycemia: Comparing tirzepatide to
Description
10.1016/j.ebiom.2020.103202 59 PeiselerM.SchwabeR.HampeJ.KubesP.HeikenwlderM.TackeF
Incidences of acute pancreatitis and pancreatic cancer were reported to be increased with use of GLP-1RAs in the US Food and Drug Administrations database studies
Associate Editor: Pedro Andr Kowacs ( 0000-0001-7770-7475 )
Jessica Lovato, a double board-certified physician specializing in obesity medicine and general surgery at Banner Health, went even further
